𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome

✍ Scribed by H. H. Wenzl; T. A. Hinterleitner; B. W. Aichbichler; P. Fickert; W. Petritsch


Book ID
108603485
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
99 KB
Volume
19
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Dosage adjustment during long-term adali
✍ William J. Sandborn; Jean-FrΓ©dΓ©ric Colombel; Stefan Schreiber; Scott E. Plevy; P πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 410 KB πŸ‘ 2 views

Background: Data from CHARM, a 56-week, randomized controlled trial of adalimumab for patients with moderately to severely active Crohn's disease (CD), were used to evaluate outcomes of adalimumab dosage adjustment. Methods: Patients randomized to blinded adalimumab 40 mg every other week (EOW) in